Cargando…
Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival
Stage III non-small cell lung cancer (NSCLC) includes a highly heterogeneous group of patients with differences in the extent and localization of disease. Many aspects of stage III disease are controversial. The data supporting treatment approaches are often subject to a number of limitations, due t...
Autores principales: | Casal-Mouriño, Ana, Ruano-Ravina, Alberto, Lorenzo-González, María, Rodríguez-Martínez, Ángeles, Giraldo-Osorio, Alexandra, Varela-Lema, Leonor, Pereiro-Brea, Tara, Barros-Dios, Juan Miguel, Valdés-Cuadrado, Luis, Pérez-Ríos, Mónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867742/ https://www.ncbi.nlm.nih.gov/pubmed/33569332 http://dx.doi.org/10.21037/tlcr.2020.03.40 |
Ejemplares similares
-
Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer
por: Hamada, Akira, et al.
Publicado: (2021) -
Mediastinal staging for non-small cell lung cancer
por: Leiro-Fernández, Virginia, et al.
Publicado: (2021) -
Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer
por: Alcibar, Olwen Leaman, et al.
Publicado: (2021) -
Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
por: Pradhan, Monika, et al.
Publicado: (2021) -
Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer
por: Reyes, Roxana, et al.
Publicado: (2021)